Clinical Personalized Medicine for Parkinson's Disease and Implications on Sleep Dysfunction
{{output}}
Personalized medicine (PM) for Parkinson's disease (PD) can range from precision genomic therapies such as ambroxol in glucocerebrosidase mutation-linked PD to treatment tailored for sleep dysfunction in nonmotor subtypes of PD. Additionally, in future pharma... ...
